Disruption of Smad5 gene leads to enhanced proliferation of high-proliferative potential precursors during embryonic hematopoiesis
- 1 January 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 101 (1) , 124-133
- https://doi.org/10.1182/blood-2002-02-0398
Abstract
SMAD proteins are downstream signal transducers of the transforming growth factor β (TGF-β) superfamily, which serve as pleiotropic regulators in embryonic and adult hematopoiesis. SMAD5, initially considered to mediate bone morphogenetic proteins (BMPs) signals, can also transduce the inhibitory signal of TGF-β1 on proliferation of hematopoietic progenitors derived from human bone marrow. To define its specific role in regulation of primitive multipotential progenitors during early embryonic hematopoiesis, we examined Smad5−/− yolk sacs at E9.0 to 9.5 and detected an elevated number of high-proliferative potential colony-forming cells (HPP-CFCs) with enhanced replating potential. To exclude the possible influence of microenvironmental deficit on embryonic hematopoiesis in vivo, we performed in vitro embryonic stem (ES) cell differentiation assay and investigated the HPP-CFCs in particular. Smad5−/− embryoid bodies (EBs) contained an elevated number of blast colony-forming cells (BL-CFCs), the in vitro equivalent of hemangioblast, in contrast to reduced proliferation of primitive erythroid precursors (Ery/Ps) within the mutant EBs. More importantly, profoundly increased frequency of HPP-CFCs, featured with a gene-dosage effect, was detected within day 6 Smad5−/−EBs compared with the wild type. In addition, Smad5−/−HPP-CFCs displayed enhanced self-renewal capacity and decreased sensitivity to TGF-β1 inhibition, suggesting a critical role of Smad5 in TGF-β1 regulation of embryonic HPP-CFCs. Consistently, reverse transcription-polymerase chain reaction analysis detected alterations of the transcription factors including GATA-2 and AML1 as well as cytokine receptors in Smad5−/− HPP-CFC colonies. Together, these data define an important function of SMAD5 in negative regulation of high-proliferative potential precursors during embryonic hematopoiesis.Keywords
This publication has 67 references indexed in Scilit:
- Characterization of the DNA-Binding Property of Smad5Biochemical and Biophysical Research Communications, 2001
- Specific dose-response effects of TGF-β1 on developmentally distinct hematopoietic stem/progenitor cells from human umbilical cord bloodThe Hematology Journal, 2000
- TrueLeukemia, 1999
- The TGF-β type II receptor in chronic myeloid leukemia: analysis of microsatellite regions and gene expressionLeukemia, 1999
- Expression of the α6A integrin splice variant in developing mouse embryonic stem cell aggregates and correlation with cardiac muscle differentiationDifferentiation, 1999
- Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCLNature, 1995
- Secretion of transforming growth factor‐β isoforms by embryonic stem cells: Isoform and latency are dependent on direction of differentiationJournal of Cellular Physiology, 1993
- Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides.The Journal of Experimental Medicine, 1991
- Characterization of murine erythropoietin receptor genesJournal of Molecular Biology, 1990
- Expression pattern of the mouse T gene and its role in mesoderm formationNature, 1990